As of February 6, 2024, a total of 8 analysts have recently published ratings on Axsome Therapeutics (NASDAQ:AXSM), offering a wide range of perspectives on the stock. Let’s take a closer look at their ratings and how they have evolved over the past few months.
Rating Total Ratings Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago
Bullish 4 1 0 3 0
Somewhat Bullish 4 0 3 1 0
Indifferent 0 0 0 0 0
Somewhat Bearish 0 0 0 0 0
Bearish 0 0 0 0 0
These ratings reflect the changing sentiments towards Axsome Therapeutics within the past 30 days, compared to the ratings from previous months.
In addition to the ratings, analysts also provide insights through their assessments of 12-month price targets. The average target currently stands at $131.38, with a high estimate of $180.00 and a low estimate of $108.00. This indicates a significant increase of 45.98% from the previous average price target of $90.00.
Let’s dive into some key insights from the analysts’ actions and price targets:
– Ashwani Verma from UBS has announced a Buy rating on Axsome Therapeutics, setting a current price target of $111.00.
– Leonid Timashev from RBC Capital has given an Outperform rating, with a current price target of $126.00.
– Charles Duncan from Cantor Fitzgerald has maintained an Overweight rating and set a current price target of $108.00.
– David Amsellem from Piper Sandler has raised both the Overweight rating and the price target to $113.00 from $90.00.
– Raghuram Selvaraju from HC Wainwright & Co. has maintained a Buy rating, with a high price target of $180.00.
Taking into account various sources, the average price target for Axsome Therapeutics is approximately $130.22, with a high forecast of $180.00.
These ratings and price targets provide valuable insights into the evolving sentiments and expectations of financial experts in relation to Axsome Therapeutics in the stock market.
AXSM Stock Performance: Mixed Day with Price Decrease and Pre-Market Rise
On February 6, 2024, AXSM stock exhibited mixed performances, with a slight decrease in price during regular market hours followed by a rise in pre-market trading. According to data from CNN Money, AXSM was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum.
The price of AXSM shares experienced a decrease of $1.32 since the market last closed, representing a 1.42% drop. The stock closed at $91.50, reflecting the decline. However, in pre-market trading, the stock managed to bounce back, rising by $2.50.
The fact that AXSM was trading near the top of its 52-week range suggests that the stock has been performing well compared to its historical price levels. This indicates that investors have been optimistic about the company’s prospects, leading to increased demand and a higher share price.
Furthermore, the stock being above its 200-day simple moving average is another positive sign. The 200-day moving average is a widely followed technical indicator used by traders and investors to identify the overall trend of a stock. When a stock is trading above its 200-day moving average, it suggests that the stock has been on an upward trend over the long term.
The decrease of $1.32 in the price of AXSM shares may be attributed to various factors such as market conditions, sector trends, or company-specific news.
However, the subsequent rise of $2.50 in pre-market trading indicates that there may be positive sentiment surrounding AXSM.
Investors should closely monitor AXSM’s performance throughout the trading day to gain a better understanding of the stock’s direction. It is essential to consider other factors such as news releases, earnings reports, or market trends that may impact the stock’s price. Conducting thorough research and consulting with a financial advisor can help investors make informed decisions about their AXSM holdings.
AXSM Stock Performance: Mixed Results and Potential Recovery in Earnings Per Share
On February 6, 2024, AXSM stock experienced mixed performances based on the available data from CNN Money.
The net income for AXSM in the past year was -$187.13 million, indicating a significant loss. However, compared to the third quarter of the same year, the net income improved by 7.4% to -$62.20 million.
In terms of year-on-year performance, AXSM’s net income decreased by 43.5%. However, it is worth noting that the net income increased by 7.4% since the previous quarter.
The earnings per share (EPS) for the past year was -$4.60, representing a significant loss per share. However, compared to the third quarter of the same year, the EPS improved by 14.17% to -$1.32 per share.
In terms of year-on-year performance, AXSM’s EPS decreased by 32.79%. However, the increase of 14.17% in EPS since the previous quarter shows a potential recovery in earnings per share.
It is important to note that the absence of total revenue data limits our ability to fully assess AXSM’s financial performance. Investors and analysts should closely monitor AXSM’s future financial reports to gain a more comprehensive understanding of the company’s performance.
